Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma

por Ruffini, Federica, Graziani, Grazia, Levati, Lauretta, Tentori, Lucio, Caporali, Simona, D’Atri, Stefania, Lacal, Pedro M
Publicado 2015

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1

por Ruffini, Federica, Levati, Lauretta, Graziani, Grazia, Caporali, Simona, Atzori, Maria Grazia, D’Atri, Stefania, Lacal, Pedro M.
Publicado 2017

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug

por Caporali, Simona, Levati, Lauretta, Graziani, Grazia, Muzi, Alessia, Atzori, Maria Grazia, Bonmassar, Enzo, Palmieri, Giuseppe, Ascierto, Paolo A, D’Atri, Stefania
Publicado 2012

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib

por Caporali, Simona, Alvino, Ester, Lacal, Pedro Miguel, Ruffini, Federica, Levati, Lauretta, Bonmassar, Laura, Scoppola, Alessandro, Marchetti, Paolo, Mastroeni, Simona, Antonini Cappellini, Gian Carlo, D’Atri, Stefania
Publicado 2017

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by i...

por Caporali, Simona, Alvino, Ester, Amaro, Adriana, Lacal, Pedro Miguel, Levati, Lauretta, Atzori, Maria Grazia, Cappellini, Gian Carlo Antonini, Ruffini, Federica, Bonmassar, Enzo, Pfeffer, Ulrich, D’Atri, Stefania
Publicado 2015

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection

por Hatch, Stephanie B, Swift, Lonnie P, Caporali, Simona, Carter, Rebecca, Hill, Esme J, MacGregor, Thomas P, D’Atri, Stefania, Middleton, Mark R, McHugh, Peter J, Sharma, Ricky A
Publicado 2014

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

por Caporali, Simona, Amaro, Adriana, Levati, Lauretta, Alvino, Ester, Lacal, Pedro Miguel, Mastroeni, Simona, Ruffini, Federica, Bonmassar, Laura, Antonini Cappellini, Gian Carlo, Felli, Nadia, Carè, Alessandra, Pfeffer, Ulrich, D’Atri, Stefania
Publicado 2019

Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma

por Pedini, Francesca, De Luca, Gabriele, Felicetti, Federica, Puglisi, Rossella, Boe, Alessandra, Arasi, Maria Beatrice, Fratini, Federica, Mattia, Gianfranco, Spada, Massimo, Caporali, Simona, Biffoni, Mauro, Giuliani, Alessandro, Carè, Alessandra, Felli, Nadia
Publicado 2019

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy

por Levati, Lauretta, Bassi, Cristian, Mastroeni, Simona, Lupini, Laura, Antonini Cappellini, Gian Carlo, Bonmassar, Laura, Alvino, Ester, Caporali, Simona, Lacal, Pedro Miguel, Narducci, Maria Grazia, Molineris, Ivan, De Galitiis, Federica, Negrini, Massimo, Russo, Giandomenico, D’Atri, Stefania
Publicado 2022